CD34 and type 2 diabetes mellitus: To confirm the presence of a specific form of mobilopathy affecting the subpopulation of CD34+NK1R+ HSPCs, we investigated an independent cohort of 24 non-diabetic individuals and 74 patients with type 2 diabetes (ESM Table 3 and ESM Fig. 2).